PMID- 1457952 OWN - NLM STAT- MEDLINE DCOM- 19930111 LR - 20131121 IS - 1058-2916 (Print) IS - 1058-2916 (Linking) VI - 38 IP - 3 DP - 1992 Jul-Sep TI - Solute clearance in continuous venovenous hemodialysis. A comparison of cuprophane, polyacrylonitrile, and polysulfone membranes. PG - M697-701 AB - Critically ill patients with ARF and MOSF were treated with continuous venovenous hemodialysis (CVVHD). The BSM 22 delivery system (CGH Medical, Denver, CO) and four different dialyzer membranes were used. Vascular access was achieved with a dual lumen catheter placed percutaneously into a large vein. Heparin was used for anticoagulation, and commercially available peritoneal dialysis fluid was used as dialysate. At a fixed blood flow rate of 100 ml/min, the dialysate inflow and outflow rates were regulated to control azotemia and fluid balance. Blood side and dialysate side clearances for urea nitrogen, creatinine, bicarbonate, and lactate were measured. All dialyzer membranes studied provided high urea nitrogen clearance approximating dialysate outflow rate and resulting in excellent control of azotemia. Some of the dialyzer membranes also had high creatinine and bicarbonate clearances. Bicarbonate loss was balanced by lactate uptake with all dialyzers. It is concluded that CVVHD is an efficient and safe therapy for acute renal failure, capable of maintaining nitrogen balance in patients with protein catabolic rates up to 2 g/kg/day. Urea nitrogen clearance is dependent upon dialysate outflow rate rather than the dialyzer membrane type or dialyzer flow geometry, and may prove to be the modality of choice for therapy of acute renal failure in unstable patients with MOSF. FAU - Ifediora, O C AU - Ifediora OC AD - Division of Nephrology, Lankenau Hospital, Wynnewood, Pennsylvania. FAU - Teehan, B P AU - Teehan BP FAU - Sigler, M H AU - Sigler MH LA - eng PT - Comparative Study PT - Journal Article PL - United States TA - ASAIO J JT - ASAIO journal (American Society for Artificial Internal Organs : 1992) JID - 9204109 RN - 0 (Acrylic Resins) RN - 0 (Bicarbonates) RN - 0 (Lactates) RN - 0 (Membranes, Artificial) RN - 0 (Polymers) RN - 0 (Sulfones) RN - 25014-41-9 (polyacrylonitrile) RN - 25135-51-7 (polysulfone P 1700) RN - 33X04XA5AT (Lactic Acid) RN - 8W8T17847W (Urea) RN - 9004-34-6 (Cellulose) RN - 9050-09-3 (cuprammonium cellulose) RN - MU72812GK0 (Creatine) SB - IM MH - Acrylic Resins MH - Acute Kidney Injury/complications/metabolism/therapy MH - Aged MH - Aged, 80 and over MH - Bicarbonates/metabolism MH - Cellulose/analogs & derivatives MH - Creatine/metabolism MH - Female MH - Humans MH - *Kidneys, Artificial MH - Kinetics MH - Lactates/metabolism MH - Lactic Acid MH - Male MH - Membranes, Artificial MH - Multiple Organ Failure/complications/metabolism/therapy MH - Polymers MH - Renal Dialysis/*methods MH - Sulfones MH - Urea/metabolism EDAT- 1992/07/01 00:00 MHDA- 1992/07/01 00:01 CRDT- 1992/07/01 00:00 PHST- 1992/07/01 00:00 [pubmed] PHST- 1992/07/01 00:01 [medline] PHST- 1992/07/01 00:00 [entrez] PST - ppublish SO - ASAIO J. 1992 Jul-Sep;38(3):M697-701.